Ontology highlight
ABSTRACT: Introduction
The aim of this study was to evaluate Dysphagia Days as a measure of symptom improvement in patients with eosinophilic esophagitis from the HEROES study.Methods
Dysphagia Days, defined as a yes answer to the following question: During any meal today, did food go down slowly or get stuck in your throat or chest? was assessed for cendakimab vs placebo.Results
A statistically significant reduction in the mean number of Dysphagia Days experienced was observed with cendakimab 360 mg vs placebo at week 16 (-4.67 vs -1.83; P = 0.0115); an even greater improvement was observed in steroid-refractory patients vs placebo (-4.48 vs -0.04; P = 0.0079).Discussion
Dysphagia Days represents a relevant clinical end point to capture dysphagia-related symptoms.
SUBMITTER: Hirano I
PROVIDER: S-EPMC10045973 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Hirano Ikuo I Rothenberg Marc E ME Zhang Sandra S de Oliveira Claudia C Charriez Christina M CM Coyne Karin S KS Bacci Elizabeth Dansie ED Dellon Evan S ES
The American journal of gastroenterology 20221220 4
<h4>Introduction</h4>The aim of this study was to evaluate Dysphagia Days as a measure of symptom improvement in patients with eosinophilic esophagitis from the HEROES study.<h4>Methods</h4>Dysphagia Days, defined as a yes answer to the following question: During any meal today, did food go down slowly or get stuck in your throat or chest? was assessed for cendakimab vs placebo.<h4>Results</h4>A statistically significant reduction in the mean number of Dysphagia Days experienced was observed wit ...[more]